[Results of Leponex treatment of schizophrenia].
D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D013607:Tablets
D014151:Anti-Anxiety Agents; D010879:Piperazines; D013607:Tablets; D001569:Benzodiazepines
Wyniki leczenia leponeksem chorych na schizofrenie